ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global First-in-Human (FIH) Services Market Research Report 2026
Published Date: 2026-01-22
|
Report Code: QYRE-Auto-7M19097
Home | Market Reports | Health| Nursing
Global First in Human FIH Services Market Research Report 2025
BUY CHAPTERS

Global First-in-Human (FIH) Services Market Research Report 2026

Code: QYRE-Auto-7M19097
Report
2026-01-22
Pages:140
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
WuXi AppTec
Allucent
ALTASCIENCES
Lonza
Syneos Health
CD BioSciences
Fortrea
Certara
Evotec AG
Aixial Group
Quotient Sciences
Sofpromed
Biotrial
Crystal Pharmatech Co., Ltd
Avania
LAXAI
Spaulding Clinical

First-in-Human (FIH) Services Market Size

The global First-in-Human (FIH) Services market was valued at US$ 751 million in 2025 and is anticipated to reach US$ 1576 million by 2032, at a CAGR of 11.3% from 2026 to 2032.

First-in-Human (FIH) Services Market

First-in-Human (FIH) Services Market

First-in-Human Services refer to specialized services that support the planning, execution, and management of First-in-Human (FIH) clinical trials. These services are critical for the successful transition of a drug or therapeutic product from preclinical development to initial testing in human subjects. FIH trials are typically the first time a new drug is administered to humans, making the associated services essential for ensuring safety, compliance, and scientific validity.First-in-Human Services are essential for minimizing risks associated with the early testing of new drugs in humans, ensuring regulatory compliance, and generating reliable data that can influence subsequent phases of drug development. These services help streamline the clinical trial process, improve efficiency, and enhance the likelihood of successful product development.
The North American market for First-in-Human (FIH) Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for First-in-Human (FIH) Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for First-in-Human (FIH) Services in Pharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of First-in-Human (FIH) Services include WuXi AppTec, Allucent, Altasciences, LAXAI, Lonza, Syneos Health, CD BioSciences, Fortrea, Certara, Evotec, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global First-in-Human (FIH) Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding First-in-Human (FIH) Services. The First-in-Human (FIH) Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global First-in-Human (FIH) Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist First-in-Human (FIH) Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of First-in-Human (FIH) Services Market Report

Report Metric Details
Report Name First-in-Human (FIH) Services Market
Accounted market size in 2025 US$ 751 million
Forecasted market size in 2032 US$ 1576 million
CAGR 11.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Drugs
  • Medical Device
Segment by Application
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic Institutions and Research Centers
  • Medical Device Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company WuXi AppTec, Allucent, Altasciences, LAXAI, Lonza, Syneos Health, CD BioSciences, Fortrea, Certara, Evotec, Aixial Group, Quotient Sciences, Sofpromed, Spaulding Clinical, Biotrial, Crystal Pharmatech Co., Ltd, Avania
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for First-in-Human (FIH) Services companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is First-in-Human (FIH) Services Market growing?

Ans: The First-in-Human (FIH) Services Market witnessing a CAGR of 11.3% during the forecast period 2026-2032.

What is the First-in-Human (FIH) Services Market size in 2032?

Ans: The First-in-Human (FIH) Services Market size in 2032 will be US$ 1576 million.

Who are the main players in the First-in-Human (FIH) Services Market report?

Ans: The main players in the First-in-Human (FIH) Services Market are WuXi AppTec, Allucent, Altasciences, LAXAI, Lonza, Syneos Health, CD BioSciences, Fortrea, Certara, Evotec, Aixial Group, Quotient Sciences, Sofpromed, Spaulding Clinical, Biotrial, Crystal Pharmatech Co., Ltd, Avania

What are the Application segmentation covered in the First-in-Human (FIH) Services Market report?

Ans: The Applications covered in the First-in-Human (FIH) Services Market report are Pharmaceutical Companies, Contract Research Organizations (CROs), Academic Institutions and Research Centers, Medical Device Companies

What are the Type segmentation covered in the First-in-Human (FIH) Services Market report?

Ans: The Types covered in the First-in-Human (FIH) Services Market report are Drugs, Medical Device

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global First-in-Human (FIH) Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Drugs
1.2.3 Medical Device
1.3 Market by Application
1.3.1 Global First-in-Human (FIH) Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Academic Institutions and Research Centers
1.3.5 Medical Device Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global First-in-Human (FIH) Services Market Perspective (2021–2032)
2.2 Global First-in-Human (FIH) Services Growth Trends by Region
2.2.1 Global First-in-Human (FIH) Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 First-in-Human (FIH) Services Historic Market Size by Region (2021–2026)
2.2.3 First-in-Human (FIH) Services Forecasted Market Size by Region (2027–2032)
2.3 First-in-Human (FIH) Services Market Dynamics
2.3.1 First-in-Human (FIH) Services Industry Trends
2.3.2 First-in-Human (FIH) Services Market Drivers
2.3.3 First-in-Human (FIH) Services Market Challenges
2.3.4 First-in-Human (FIH) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top First-in-Human (FIH) Services Players by Revenue
3.1.1 Global Top First-in-Human (FIH) Services Players by Revenue (2021–2026)
3.1.2 Global First-in-Human (FIH) Services Revenue Market Share by Players (2021–2026)
3.2 Global Top First-in-Human (FIH) Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by First-in-Human (FIH) Services Revenue
3.4 Global First-in-Human (FIH) Services Market Concentration Ratio
3.4.1 Global First-in-Human (FIH) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by First-in-Human (FIH) Services Revenue in 2025
3.5 Global Key Players of First-in-Human (FIH) Services Head Offices and Areas Served
3.6 Global Key Players of First-in-Human (FIH) Services, Products and Applications
3.7 Global Key Players of First-in-Human (FIH) Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 First-in-Human (FIH) Services Breakdown Data by Type
4.1 Global First-in-Human (FIH) Services Historic Market Size by Type (2021–2026)
4.2 Global First-in-Human (FIH) Services Forecasted Market Size by Type (2027–2032)
5 First-in-Human (FIH) Services Breakdown Data by Application
5.1 Global First-in-Human (FIH) Services Historic Market Size by Application (2021–2026)
5.2 Global First-in-Human (FIH) Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America First-in-Human (FIH) Services Market Size (2021–2032)
6.2 North America First-in-Human (FIH) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America First-in-Human (FIH) Services Market Size by Country (2021–2026)
6.4 North America First-in-Human (FIH) Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe First-in-Human (FIH) Services Market Size (2021–2032)
7.2 Europe First-in-Human (FIH) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe First-in-Human (FIH) Services Market Size by Country (2021–2026)
7.4 Europe First-in-Human (FIH) Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific First-in-Human (FIH) Services Market Size (2021–2032)
8.2 Asia-Pacific First-in-Human (FIH) Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2021–2026)
8.4 Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America First-in-Human (FIH) Services Market Size (2021–2032)
9.2 Latin America First-in-Human (FIH) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America First-in-Human (FIH) Services Market Size by Country (2021–2026)
9.4 Latin America First-in-Human (FIH) Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa First-in-Human (FIH) Services Market Size (2021–2032)
10.2 Middle East & Africa First-in-Human (FIH) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2021–2026)
10.4 Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Details
11.1.2 WuXi AppTec Business Overview
11.1.3 WuXi AppTec First-in-Human (FIH) Services Introduction
11.1.4 WuXi AppTec Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.1.5 WuXi AppTec Recent Development
11.2 Allucent
11.2.1 Allucent Company Details
11.2.2 Allucent Business Overview
11.2.3 Allucent First-in-Human (FIH) Services Introduction
11.2.4 Allucent Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.2.5 Allucent Recent Development
11.3 Altasciences
11.3.1 Altasciences Company Details
11.3.2 Altasciences Business Overview
11.3.3 Altasciences First-in-Human (FIH) Services Introduction
11.3.4 Altasciences Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.3.5 Altasciences Recent Development
11.4 LAXAI
11.4.1 LAXAI Company Details
11.4.2 LAXAI Business Overview
11.4.3 LAXAI First-in-Human (FIH) Services Introduction
11.4.4 LAXAI Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.4.5 LAXAI Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza First-in-Human (FIH) Services Introduction
11.5.4 Lonza Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.5.5 Lonza Recent Development
11.6 Syneos Health
11.6.1 Syneos Health Company Details
11.6.2 Syneos Health Business Overview
11.6.3 Syneos Health First-in-Human (FIH) Services Introduction
11.6.4 Syneos Health Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.6.5 Syneos Health Recent Development
11.7 CD BioSciences
11.7.1 CD BioSciences Company Details
11.7.2 CD BioSciences Business Overview
11.7.3 CD BioSciences First-in-Human (FIH) Services Introduction
11.7.4 CD BioSciences Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.7.5 CD BioSciences Recent Development
11.8 Fortrea
11.8.1 Fortrea Company Details
11.8.2 Fortrea Business Overview
11.8.3 Fortrea First-in-Human (FIH) Services Introduction
11.8.4 Fortrea Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.8.5 Fortrea Recent Development
11.9 Certara
11.9.1 Certara Company Details
11.9.2 Certara Business Overview
11.9.3 Certara First-in-Human (FIH) Services Introduction
11.9.4 Certara Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.9.5 Certara Recent Development
11.10 Evotec
11.10.1 Evotec Company Details
11.10.2 Evotec Business Overview
11.10.3 Evotec First-in-Human (FIH) Services Introduction
11.10.4 Evotec Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.10.5 Evotec Recent Development
11.11 Aixial Group
11.11.1 Aixial Group Company Details
11.11.2 Aixial Group Business Overview
11.11.3 Aixial Group First-in-Human (FIH) Services Introduction
11.11.4 Aixial Group Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.11.5 Aixial Group Recent Development
11.12 Quotient Sciences
11.12.1 Quotient Sciences Company Details
11.12.2 Quotient Sciences Business Overview
11.12.3 Quotient Sciences First-in-Human (FIH) Services Introduction
11.12.4 Quotient Sciences Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.12.5 Quotient Sciences Recent Development
11.13 Sofpromed
11.13.1 Sofpromed Company Details
11.13.2 Sofpromed Business Overview
11.13.3 Sofpromed First-in-Human (FIH) Services Introduction
11.13.4 Sofpromed Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.13.5 Sofpromed Recent Development
11.14 Spaulding Clinical
11.14.1 Spaulding Clinical Company Details
11.14.2 Spaulding Clinical Business Overview
11.14.3 Spaulding Clinical First-in-Human (FIH) Services Introduction
11.14.4 Spaulding Clinical Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.14.5 Spaulding Clinical Recent Development
11.15 Biotrial
11.15.1 Biotrial Company Details
11.15.2 Biotrial Business Overview
11.15.3 Biotrial First-in-Human (FIH) Services Introduction
11.15.4 Biotrial Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.15.5 Biotrial Recent Development
11.16 Crystal Pharmatech Co., Ltd
11.16.1 Crystal Pharmatech Co., Ltd Company Details
11.16.2 Crystal Pharmatech Co., Ltd Business Overview
11.16.3 Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Introduction
11.16.4 Crystal Pharmatech Co., Ltd Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.16.5 Crystal Pharmatech Co., Ltd Recent Development
11.17 Avania
11.17.1 Avania Company Details
11.17.2 Avania Business Overview
11.17.3 Avania First-in-Human (FIH) Services Introduction
11.17.4 Avania Revenue in First-in-Human (FIH) Services Business (2021–2026)
11.17.5 Avania Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
WuXi AppTec
Allucent
ALTASCIENCES
Lonza
Syneos Health
CD BioSciences
Fortrea
Certara
Evotec AG
Aixial Group
Quotient Sciences
Sofpromed
Biotrial
Crystal Pharmatech Co., Ltd
Avania
LAXAI
Spaulding Clinical
List of Tables
 Table 1. Global First-in-Human (FIH) Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Drugs
 Table 3. Key Players of Medical Device
 Table 4. Global First-in-Human (FIH) Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global First-in-Human (FIH) Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global First-in-Human (FIH) Services Market Size by Region (US$ Million), 2021–2026
 Table 7. Global First-in-Human (FIH) Services Market Share by Region (2021–2026)
 Table 8. Global First-in-Human (FIH) Services Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global First-in-Human (FIH) Services Market Share by Region (2027–2032)
 Table 10. First-in-Human (FIH) Services Market Trends
 Table 11. First-in-Human (FIH) Services Market Drivers
 Table 12. First-in-Human (FIH) Services Market Challenges
 Table 13. First-in-Human (FIH) Services Market Restraints
 Table 14. Global First-in-Human (FIH) Services Revenue by Players (US$ Million), 2021–2026
 Table 15. Global First-in-Human (FIH) Services Market Share by Players (2021–2026)
 Table 16. Global Top First-in-Human (FIH) Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on First-in-Human (FIH) Services Revenue, 2025
 Table 17. Ranking of Global Top First-in-Human (FIH) Services Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by First-in-Human (FIH) Services Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of First-in-Human (FIH) Services, Headquarters and Area Served
 Table 20. Global Key Players of First-in-Human (FIH) Services, Products and Applications
 Table 21. Global Key Players of First-in-Human (FIH) Services, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global First-in-Human (FIH) Services Market Size by Type (US$ Million), 2021–2026
 Table 24. Global First-in-Human (FIH) Services Revenue Market Share by Type (2021–2026)
 Table 25. Global First-in-Human (FIH) Services Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global First-in-Human (FIH) Services Revenue Market Share by Type (2027–2032)
 Table 27. Global First-in-Human (FIH) Services Market Size by Application (US$ Million), 2021–2026
 Table 28. Global First-in-Human (FIH) Services Revenue Market Share by Application (2021–2026)
 Table 29. Global First-in-Human (FIH) Services Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global First-in-Human (FIH) Services Revenue Market Share by Application (2027–2032)
 Table 31. North America First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America First-in-Human (FIH) Services Market Size by Country (US$ Million), 2021–2026
 Table 33. North America First-in-Human (FIH) Services Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe First-in-Human (FIH) Services Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe First-in-Human (FIH) Services Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific First-in-Human (FIH) Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific First-in-Human (FIH) Services Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific First-in-Human (FIH) Services Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America First-in-Human (FIH) Services Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America First-in-Human (FIH) Services Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa First-in-Human (FIH) Services Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa First-in-Human (FIH) Services Market Size by Country (US$ Million), 2027–2032
 Table 46. WuXi AppTec Company Details
 Table 47. WuXi AppTec Business Overview
 Table 48. WuXi AppTec First-in-Human (FIH) Services Product
 Table 49. WuXi AppTec Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 50. WuXi AppTec Recent Development
 Table 51. Allucent Company Details
 Table 52. Allucent Business Overview
 Table 53. Allucent First-in-Human (FIH) Services Product
 Table 54. Allucent Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 55. Allucent Recent Development
 Table 56. Altasciences Company Details
 Table 57. Altasciences Business Overview
 Table 58. Altasciences First-in-Human (FIH) Services Product
 Table 59. Altasciences Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 60. Altasciences Recent Development
 Table 61. LAXAI Company Details
 Table 62. LAXAI Business Overview
 Table 63. LAXAI First-in-Human (FIH) Services Product
 Table 64. LAXAI Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 65. LAXAI Recent Development
 Table 66. Lonza Company Details
 Table 67. Lonza Business Overview
 Table 68. Lonza First-in-Human (FIH) Services Product
 Table 69. Lonza Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 70. Lonza Recent Development
 Table 71. Syneos Health Company Details
 Table 72. Syneos Health Business Overview
 Table 73. Syneos Health First-in-Human (FIH) Services Product
 Table 74. Syneos Health Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 75. Syneos Health Recent Development
 Table 76. CD BioSciences Company Details
 Table 77. CD BioSciences Business Overview
 Table 78. CD BioSciences First-in-Human (FIH) Services Product
 Table 79. CD BioSciences Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 80. CD BioSciences Recent Development
 Table 81. Fortrea Company Details
 Table 82. Fortrea Business Overview
 Table 83. Fortrea First-in-Human (FIH) Services Product
 Table 84. Fortrea Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 85. Fortrea Recent Development
 Table 86. Certara Company Details
 Table 87. Certara Business Overview
 Table 88. Certara First-in-Human (FIH) Services Product
 Table 89. Certara Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 90. Certara Recent Development
 Table 91. Evotec Company Details
 Table 92. Evotec Business Overview
 Table 93. Evotec First-in-Human (FIH) Services Product
 Table 94. Evotec Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 95. Evotec Recent Development
 Table 96. Aixial Group Company Details
 Table 97. Aixial Group Business Overview
 Table 98. Aixial Group First-in-Human (FIH) Services Product
 Table 99. Aixial Group Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 100. Aixial Group Recent Development
 Table 101. Quotient Sciences Company Details
 Table 102. Quotient Sciences Business Overview
 Table 103. Quotient Sciences First-in-Human (FIH) Services Product
 Table 104. Quotient Sciences Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 105. Quotient Sciences Recent Development
 Table 106. Sofpromed Company Details
 Table 107. Sofpromed Business Overview
 Table 108. Sofpromed First-in-Human (FIH) Services Product
 Table 109. Sofpromed Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 110. Sofpromed Recent Development
 Table 111. Spaulding Clinical Company Details
 Table 112. Spaulding Clinical Business Overview
 Table 113. Spaulding Clinical First-in-Human (FIH) Services Product
 Table 114. Spaulding Clinical Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 115. Spaulding Clinical Recent Development
 Table 116. Biotrial Company Details
 Table 117. Biotrial Business Overview
 Table 118. Biotrial First-in-Human (FIH) Services Product
 Table 119. Biotrial Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 120. Biotrial Recent Development
 Table 121. Crystal Pharmatech Co., Ltd Company Details
 Table 122. Crystal Pharmatech Co., Ltd Business Overview
 Table 123. Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Product
 Table 124. Crystal Pharmatech Co., Ltd Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 125. Crystal Pharmatech Co., Ltd Recent Development
 Table 126. Avania Company Details
 Table 127. Avania Business Overview
 Table 128. Avania First-in-Human (FIH) Services Product
 Table 129. Avania Revenue in First-in-Human (FIH) Services Business (US$ Million), 2021–2026
 Table 130. Avania Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. First-in-Human (FIH) Services Picture
 Figure 2. Global First-in-Human (FIH) Services Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global First-in-Human (FIH) Services Market Share by Type: 2025 vs 2032
 Figure 4. Drugs Features
 Figure 5. Medical Device Features
 Figure 6. Global First-in-Human (FIH) Services Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global First-in-Human (FIH) Services Market Share by Application: 2025 vs 2032
 Figure 8. Pharmaceutical Companies Case Studies
 Figure 9. Contract Research Organizations (CROs) Case Studies
 Figure 10. Academic Institutions and Research Centers Case Studies
 Figure 11. Medical Device Companies Case Studies
 Figure 12. First-in-Human (FIH) Services Report Years Considered
 Figure 13. Global First-in-Human (FIH) Services Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global First-in-Human (FIH) Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global First-in-Human (FIH) Services Market Share by Region: 2025 vs 2032
 Figure 16. Global First-in-Human (FIH) Services Market Share by Players in 2025
 Figure 17. Global First-in-Human (FIH) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by First-in-Human (FIH) Services Revenue in 2025
 Figure 19. North America First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America First-in-Human (FIH) Services Market Share by Country (2021–2032)
 Figure 21. United States First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe First-in-Human (FIH) Services Market Share by Country (2021–2032)
 Figure 25. Germany First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific First-in-Human (FIH) Services Market Share by Region (2021–2032)
 Figure 33. China First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America First-in-Human (FIH) Services Market Share by Country (2021–2032)
 Figure 41. Mexico First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa First-in-Human (FIH) Services Market Share by Country (2021–2032)
 Figure 45. Israel First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE First-in-Human (FIH) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. WuXi AppTec Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 49. Allucent Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 50. Altasciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 51. LAXAI Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 52. Lonza Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 53. Syneos Health Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 54. CD BioSciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 55. Fortrea Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 56. Certara Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 57. Evotec Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 58. Aixial Group Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 59. Quotient Sciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 60. Sofpromed Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 61. Spaulding Clinical Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 62. Biotrial Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 63. Crystal Pharmatech Co., Ltd Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 64. Avania Revenue Growth Rate in First-in-Human (FIH) Services Business (2021–2026)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Preclinical Research Service Market Research Report 2024
Global Animal Model Services Market Research Report 2025
Global Clinical Trial Support Service Market Research Report 2024
Global Clinical Trial Manufacturing Service Market Research Report 2025
Global Drug Safety Testing Market Research Report 2025
Global Clinical Trial Translation Service Market Research Report 2024
Global Preclinical Toxicology Testing Service Market Research Report 2024
Global In Vitro Assay Development Service Market Research Report 2024
Global Life Scientific Services Market Research Report 2024
Global Clinical Safety and Pharmacovigilance Services Market Research Report 2024
Global In Vitro Fertilization Service Market Research Report 2025
Global Pre Clinical CROs Services Market Research Report 2024
Global Human Medical Device Design and Development Services Market Research Report 2024
Global Preclinical Toxicology Service Market Research Report 2024
Global First in Human FIH Supplies Market Research Report 2025
Global Cardiac Safety Assessment Services Market Research Report 2025
Global Pre Clinical Implants Testing Service Market Research Report 2024
Global Nonclinical Safety Assessment Service Market Research Report 2025
Global Clinical Trial Technical Services Market Research Report 2024
Global Healthcare Due Diligence Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions